Your web browser does not support JavaScript, but it does not affect browsing through the rest of the web site. Go to Main Content

Targeted Drug Development


Targeted Drug Development

Application and Product

Protein Drug

  • Novel Collagen Scaffold Antibodies for the Treatment of Autoimmune Diseases and Solid Tumor 

Small-Molecule Drug

  • ITRI-260 – a Drug Candidate for Acute Myeloid Leukemia
  • Liposomal Endorphin for Pain Treatment
  • Anti-brain Tumor New Drug using Cross-Blood-Brain Barrier DDS
  • Neurologic New Drug Development (for Alzheimer's disease, Parkinson's disease, Schizophrenia) using Sustained Release DDS (PLGA microsphere formulation)
  • Anti-colon Cancer Drug using Nanopolymeric Micelle Formulation
  • Oral Delivery Formulation on Calcitonin and Insulin
  • The Development and Pilot Manufacture of New CINV Transdermal Patch
  • Anti-acne Liposomal Gel 

Herbal Medicine

  • Anti-hepatitis C Composition and Method of Preparation
  • A Botanical Immune Modulator and Method of Preparation
  • A Composition for Decreasing Ethanol Concentration in Blood After Consuming Alcohols
  • Production of Bupleurum Polysaccharides from Plant Cell Culture 


  • Customized LIMS (Laboratory Information Management System) and GxP Management System


Biomedical Technology and Device Research Laboratories



More Information